Aduhelm’s Post-Marketing Studies: At Least One More Data Dump Likely Required By NIH

 
• By Sarah Karlin-Smith
  
puzzle in shape of human head with missing pieces in brain
Clinicaltrials.gov reporting requirements should help fill in some data gaps on Aduhelm despite end of commercialization. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from United States

More from North America